Chief Business Officer
Executive Leadership
CMC Biologics
Denmark
Robert (Bob) Broeze joined CMC Biologics in 2015 and serves as the Chief Business Officer, responsible for global sales and marketing. He has over 30 years of experience in the biopharmaceutical and contract manufacturing industries including positions as Senior VP, Business Development at Gallus Biopharmaceuticals, LLC (now Patheon Biologics) and Chief Commercial Officer and Chief Executive Officer at Laureate BioPharma. His technical expertise spans research, development, protein characterization, validation, testing and cGMP manufacture of biopharmaceutical products, from pilot to Phase III clinical and commercial scale with a strong emphasis on monoclonal antibody products for therapeutic and diagnostic use. He also held senior positions in R&D and operations at Purdue BioPharma L.P., Bard BioPharma L.P and at Cytogen Corporation. Bob is a graduate of Rensselaer Polytechnic Institute where he earned his BS and Ph.D. degrees.
Biopharmaceutical